Arterial structural and functional alterations in uraemia

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Vascular Biology

Background:

• Cardiovascular disease (CVD) is a major cause of mortality in end-stage renal disease (ESRD) patients.
• Damage to large conduit arteries, involving atherosclerosis and arteriosclerosis, underlies many CVD complications in ESRD.
• Arteriosclerosis in ESRD manifests as arterial dilation, hypertrophy, and stiffening, mimicking accelerated aging.

Purpose of the Study:

• To elucidate the mechanisms of arterial damage in ESRD.
• To highlight the clinical consequences of arterial stiffening in ESRD.
• To establish arterial remodelling and stiffening as predictors of mortality in ESRD.

Main Methods:

• Review of epidemiological and clinical studies on ESRD patients.
• Analysis of the roles of atherosclerosis and arteriosclerosis in vascular complications.
• Examination of the clinical characteristics and consequences of arterial stiffening.

Main Results:

• Arterial disease contributes to high rates of ischemic heart disease, peripheral artery disease, left ventricular hypertrophy, and heart failure in ESRD.
• Arteriosclerosis leads to increased pulse pressure due to isolated systolic hypertension.
• Arterial stiffening increases left ventricular afterload, myocardial oxygen demand, and alters coronary blood flow.

Conclusions:

• Arterial remodelling and stiffening are independent predictors of overall and cardiac mortality in ESRD.
• Understanding these vascular changes is crucial for managing CVD risk in ESRD patients.
• The arterial changes in ESRD represent a form of accelerated aging with significant clinical implications.